An atypical antipsychotic
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

BMY 14802 (hydrochloride)

Item No. 42264

Technical Information
Formal Name
α-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol, monohydrochloride
CAS Number
105565-55-7
Synonyms
  • BMS 181100
Molecular Formula
C18H22F2N4O • HCl
Formula Weight
Purity
≥98%
Formulation
A solid
DMSO: Sparingly soluble: 1-10 mg/mlEthanol: Slightly soluble: 0.1-1 mg/ml
SMILES
FC1=CC=C(C(CCCN2CCN(C3=NC=C(F)C=N3)CC2)O)C=C1.Cl
InChi Code
InChI=1S/C18H22F2N4O.ClH/c19-15-5-3-14(4-6-15)17(25)2-1-7-23-8-10-24(11-9-23)18-21-12-16(20)13-22-18;/h3-6,12-13,17,25H,1-2,7-11H2;1H
InChi Key
NIBVEFRJDFVQLM-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Wet ice in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    BMY 14802 is an atypical antipsychotic.1 It selectively binds to σ receptors over α1-adrenergic receptors (α1-ARs) and dopamine D2 receptors (IC50s = 112, 520, and 6,340 nM, respectively). In vivo, BMY 14802 inhibits the conditioned avoidance response and apomorphine-induced stereotypy in rats (ED50s = 26.4 and 33 mg/kg, respectively).

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Yevich, J.P., New, J.S., Lobeck, W.G., et alSynthesis and biological characterization of ɑ-(4-fluorophenyl)-4-(5-fluoro-2-pyrimidinyl)-1-piperazinebutanol and analogues as potential atypical antipsychotic agents. J. Med. Chem. 35(24), 4516-4525 (1992).